fluorouracil and reparixin

fluorouracil has been researched along with reparixin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hu, W; Li, J; Luo, B; Luo, G; Wang, H; Wang, J; Wang, K; Wang, W; Wen, J; Yu, J	1

Other Studies

1 other study(ies) available for fluorouracil and reparixin

Article	Year
Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil. International journal of oncology, 2016, Volume: 48, Issue:4 Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Mice; Receptors, Interleukin-8A; Receptors, Interleukin-8B; Signal Transduction; Stomach Neoplasms; Sulfonamides; Xenograft Model Antitumor Assays	2016

Article

Year

Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil.

International journal of oncology, 2016, Volume: 48, Issue:4

Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Mice; Receptors, Interleukin-8A; Receptors, Interleukin-8B; Signal Transduction; Stomach Neoplasms; Sulfonamides; Xenograft Model Antitumor Assays

2016